Table 2 IgRh prophylaxis summary
Newborn phenotype | RHD + | RHD - | ND | Total | ||||
|---|---|---|---|---|---|---|---|---|
Genotyping arm | ||||||||
Number of patients | 368 | (100%) | 136 | (100%) | 11 | (100%) | 515 | (100%) |
At least one injection | 366 | (99%) | 24 | (18%) | 8 | (73%) | 397 | (77%) |
prophylaxis | 320 | (87%) | 10 | (7%) | 6 | (55%) | 336 | (65%) |
obstetrical event | 95 | (26%) | 16 | (12%) | 2 | (18%) | 113 | (22%) |
postpartum | 346 | (94%) | 1 | (1%) | 8 | (73%) | 354 | (69%) |
No injection | 2 | (1%) | 112 | (82%) | 3 | (27%) | 118 | (23%) |
Control arm | ||||||||
Number of patients | 212 | (100%) | 100 | (100%) | 23 | (100%) | 335 | (100%) |
At least one injection | 211 | (99.5%) | 85 | (85%) | 19 | (83%) | 315 | (94%) |
prophylaxis | 174 | (82%) | 73 | (73%) | 14 | (61%) | 261 | (78%) |
obstetrical event | 50 | (24%) | 19 | (19%) | 5 | (22%) | 74 | (22%) |
postpartum | 198 | (93%) | 2 | (2%) | 4 | (17%) | 204 | (61%) |
No injection | 1 | (0.5%) | 15 | (15%) | 4 | (17%) | 20 | (6%) |